Theratechnologies Inc.

-0.02 (-1.03%)
4:51:29 PM EDT: $1.42 -0.02 (-1.05%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)34.73M
Current PEN/A
Forward PE N/A
2yr Forward PE 9.6
See more stats
Estimates Current Quarter
Revenue$23.98 Million
Adjusted EPS$0.03
See more estimates
10-Day MA$1.43
50-Day MA$1.31
200-Day MA$1.49
See more pivots

Theratechnologies Inc. Stock, NASDAQ:THTX

2015 Peel Street, 11th floor, Montr�©al, Qu�©bec H3A 1T8
Phone: +1.514.336.7800
Number of Employees: 114


Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montr�©al, Canada.